164 related articles for article (PubMed ID: 16055130)
1. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.
Pai JK; Kraft P; Cannuscio CC; Manson JE; Rexrode KM; Albert CM; Hunter D; Rimm EB
Atherosclerosis; 2006 May; 186(1):132-9. PubMed ID: 16055130
[TBL] [Abstract][Full Text] [Related]
2. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients.
Kallel A; Abdessalem S; Sédiri Y; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
Clin Biochem; 2012 Apr; 45(6):420-4. PubMed ID: 22285384
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.
González P; Alvarez R; Batalla A; Reguero JR; Alvarez V; Astudillo A; Cubero GI; Cortina A; Coto E
Genes Immun; 2001 Jun; 2(4):191-5. PubMed ID: 11477473
[TBL] [Abstract][Full Text] [Related]
6. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
10. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
11. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
Huerta C; Alvarez V; Mata IF; Coto E; Ribacoba R; Martínez C; Blázquez M; Guisasola LM; Salvador C; Lahoz CH; Peña J
Neurosci Lett; 2004 Nov; 370(2-3):151-4. PubMed ID: 15488313
[TBL] [Abstract][Full Text] [Related]
12. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications.
Yang B; Houlberg K; Millward A; Demaine A
Cytokine; 2004 May; 26(3):114-21. PubMed ID: 15135805
[TBL] [Abstract][Full Text] [Related]
14. Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population.
Lewandowska M; Trzeciak WH; Jagodzinski PP
Genetika; 2003 Jun; 39(6):831-3. PubMed ID: 12884524
[TBL] [Abstract][Full Text] [Related]
15. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.
Zhao X; Gharizadeh B; Hjelmström P; Pirskanen R; Nyrén P; Lefvert AK; Ghaderi M
Int J Mol Med; 2003 Nov; 12(5):749-53. PubMed ID: 14533004
[TBL] [Abstract][Full Text] [Related]
16. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
[TBL] [Abstract][Full Text] [Related]
18. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Kuipers IM; Lam J; Ottenkamp J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Clin Exp Immunol; 2007 Oct; 150(1):83-90. PubMed ID: 17672867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
